Rosenstock J

References (4)

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes - Rosenstock_2011_Diabet.Med_28_464
Author(s) : Rosenstock J , Lewin AJ , Norwood P , Somayaji V , Nguyen TT , Teeter JG , Johnson SL , Dai H , Terra SG
Ref : Diabet Med , 28 :464 , 2011
Abstract : Rosenstock_2011_Diabet.Med_28_464
ESTHER : Rosenstock_2011_Diabet.Med_28_464
PubMedSearch : Rosenstock_2011_Diabet.Med_28_464
PubMedID: 21392067

Title : Reflecting on type 2 diabetes prevention: more questions than answers! - Rosenstock_2007_Diabetes.Obes.Metab_9 Suppl 1_3
Author(s) : Rosenstock J
Ref : Diabetes Obes Metab , 9 Suppl 1 :3 , 2007
Abstract : Rosenstock_2007_Diabetes.Obes.Metab_9 Suppl 1_3
ESTHER : Rosenstock_2007_Diabetes.Obes.Metab_9 Suppl 1_3
PubMedSearch : Rosenstock_2007_Diabetes.Obes.Metab_9 Suppl 1_3
PubMedID: 17877541

Title : Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus - Rosenstock_2007_Curr.Opin.Endocrinol.Diabetes.Obes_14_98
Author(s) : Rosenstock J , Zinman B
Ref : Curr Opin Endocrinol Diabetes Obes , 14 :98 , 2007
Abstract : Rosenstock_2007_Curr.Opin.Endocrinol.Diabetes.Obes_14_98
ESTHER : Rosenstock_2007_Curr.Opin.Endocrinol.Diabetes.Obes_14_98
PubMedSearch : Rosenstock_2007_Curr.Opin.Endocrinol.Diabetes.Obes_14_98
PubMedID: 17940427

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study - Rosenstock_2006_Clin.Ther_28_1556
Author(s) : Rosenstock J , Brazg R , Andryuk PJ , Lu K , Stein P
Ref : Clin Ther , 28 :1556 , 2006
Abstract : Rosenstock_2006_Clin.Ther_28_1556
ESTHER : Rosenstock_2006_Clin.Ther_28_1556
PubMedSearch : Rosenstock_2006_Clin.Ther_28_1556
PubMedID: 17157112